Eagle Pharmaceuticals
EGRX
#9999
Rank
โ‚น0.60 B
Marketcap
โ‚น46.71
Share price
-8.33%
Change (1 day)
-88.67%
Change (1 year)

Revenue for Eagle Pharmaceuticals (EGRX)

Revenue in 2023 (TTM): โ‚น21.14 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น21.87 Billion. In 2022 the company made a revenue of โ‚น26.19 Billion an increase over the revenue in the year 2021 that were of โ‚น12.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eagle Pharmaceuticals from 2013 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น21.14 B-19.3%
2022 โ‚น26.19 B105.19%
2021 โ‚น12.76 B-7.04%
2020 โ‚น13.73 B-1.68%
2019 โ‚น13.96 B-6.34%
2018 โ‚น14.91 B-1.31%
2017 โ‚น15.11 B17.38%
2016 โ‚น12.87 B192.56%
2015 โ‚น4.40 B261.54%
2014 โ‚น1.21 B11.4%
2013 โ‚น1.09 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น7.447 T 33,949.96%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.418 T 15,529.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น4.241 T 19,290.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น1.424 T 6,411.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚น2.763 T 12,532.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.470 T 15,766.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.028 T 18,317.71%๐Ÿ‡บ๐Ÿ‡ธ USA